HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
Adenocarcinoma
/ pathology
Adult
Carcinoma, Endometrioid
/ pathology
DNA, Viral
/ genetics
Female
Humans
In Situ Hybridization
Middle Aged
Ovarian Neoplasms
/ secondary
Papillomaviridae
/ genetics
Papillomavirus Infections
/ complications
Prognosis
Uterine Cervical Neoplasms
/ pathology
Virus Integration
/ genetics
Cervical neoplasia
HPV
Integration
Ovarian metastasis
p16
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
23 Apr 2019
23 Apr 2019
Historique:
received:
03
12
2018
accepted:
05
04
2019
entrez:
25
4
2019
pubmed:
25
4
2019
medline:
6
8
2019
Statut:
epublish
Résumé
Most endocervical adenocarcinomas are human papillomavirus (HPV)-related cancers associated with p16 immunostaining. Ovarian metastasis from cervical cancer is a rare phenomenon, the mechanism of dissemination remains unclear. The diagnosis of metastasis may be difficult to establish when the ovarian neoplasm presents features consistent with primary tumor. Immunohistochemical expression of p16 in ovarian tumors can guide the diagnosis of metastasis from HPV-related cervical cancer, but p16 positivity is nonspecific. Identical HPV genotype in the paired endocervical and ovarian tumors is a better marker for cervical origin, which may also be confirmed by identical HPV integration site. Two women presented with HPV18 cervical adenocarcinoma. No signs of disease were visible on MRI after treatment. After several years of follow-up, mucinous ovarian tumors were discovered in both patients. Molecular analyses showed that the ovarian lesions were HPV18-positive; indicating a primary cervical origin. A third woman was diagnosed with grade 1 ovarian endometrioid carcinoma with no peritoneal carcinomatosis. Final histological examination and HPV genotyping revealed HPV18-related in situ endometrioid adenocarcinoma in the endocervix and HPV18-related invasive endometrioid adenocarcinoma in the endometrium and both ovaries. Additional molecular analyses performed in two patients identified the same HPV integration sites in both the ovarian and cervical tumors, confirming that the ovarian mass was a metastasis from the cervical adenocarcinoma. We report three new cases of ovarian neoplasia in which the diagnosis of metastasis from cervical cancer was supported by the same HPV genotype and the same integration site in the paired cervical and ovarian tumors. To our knowledge, this is the first report of molecular evidence of the cervical origin of an ovarian metastasis. HPV screening should be performed in ovarian tumors for all patients with history of cervical neoplasia.
Sections du résumé
BACKGROUND
BACKGROUND
Most endocervical adenocarcinomas are human papillomavirus (HPV)-related cancers associated with p16 immunostaining. Ovarian metastasis from cervical cancer is a rare phenomenon, the mechanism of dissemination remains unclear. The diagnosis of metastasis may be difficult to establish when the ovarian neoplasm presents features consistent with primary tumor. Immunohistochemical expression of p16 in ovarian tumors can guide the diagnosis of metastasis from HPV-related cervical cancer, but p16 positivity is nonspecific. Identical HPV genotype in the paired endocervical and ovarian tumors is a better marker for cervical origin, which may also be confirmed by identical HPV integration site.
CASE PRESENTATION
METHODS
Two women presented with HPV18 cervical adenocarcinoma. No signs of disease were visible on MRI after treatment. After several years of follow-up, mucinous ovarian tumors were discovered in both patients. Molecular analyses showed that the ovarian lesions were HPV18-positive; indicating a primary cervical origin. A third woman was diagnosed with grade 1 ovarian endometrioid carcinoma with no peritoneal carcinomatosis. Final histological examination and HPV genotyping revealed HPV18-related in situ endometrioid adenocarcinoma in the endocervix and HPV18-related invasive endometrioid adenocarcinoma in the endometrium and both ovaries. Additional molecular analyses performed in two patients identified the same HPV integration sites in both the ovarian and cervical tumors, confirming that the ovarian mass was a metastasis from the cervical adenocarcinoma.
CONCLUSION
CONCLUSIONS
We report three new cases of ovarian neoplasia in which the diagnosis of metastasis from cervical cancer was supported by the same HPV genotype and the same integration site in the paired cervical and ovarian tumors. To our knowledge, this is the first report of molecular evidence of the cervical origin of an ovarian metastasis. HPV screening should be performed in ovarian tumors for all patients with history of cervical neoplasia.
Identifiants
pubmed: 31014281
doi: 10.1186/s12885-019-5582-8
pii: 10.1186/s12885-019-5582-8
pmc: PMC6480742
doi:
Substances chimiques
DNA, Viral
0
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
375Références
Int J Cancer. 2001 Apr 1;92(1):9-17
pubmed: 11279600
J Pathol. 2003 Dec;201(4):535-43
pubmed: 14648656
Gynecol Oncol. 2006 May;101(2):234-7
pubmed: 16300819
Am J Surg Pathol. 2005 Dec;29(12):1686-7; author reply 1687-9
pubmed: 16327448
Int J Gynecol Cancer. 2006 Jan-Feb;16(1):347-53
pubmed: 16445657
Am J Surg Pathol. 2007 May;31(5):653-63
pubmed: 17460447
Int J Gynecol Pathol. 2010 Jan;29(1):88-92
pubmed: 19952931
J Pathol. 2010 Jul;221(3):320-30
pubmed: 20527025
Lancet Oncol. 2010 Nov;11(11):1048-56
pubmed: 20952254
J Clin Oncol. 2011 May 1;29(13):1785-94
pubmed: 21220591
J Low Genit Tract Dis. 2015 Oct;19(4):e60-3
pubmed: 26360235
Gynecol Oncol Rep. 2015 Apr 11;13:23-5
pubmed: 26425714
Mod Pathol. 2016 Jan;29 Suppl 1:S12-28
pubmed: 26715171
Oncotarget. 2016 Oct 4;7(40):64665-64673
pubmed: 27572321
NPJ Genom Med. 2016 Mar 16;1:16004
pubmed: 29263809
J Clin Oncol. 1998 Aug;16(8):2613-9
pubmed: 9704710